Tacalyx is a biotechnology company that develops novel anti-TACA immunotherapies to treat cancer and contentious diseases.
Business Model:
Revenue: $3M
Employees: 2-10
Address: Mullerstr. 178
City: Berlin
State: berlin
Zip: 13353
Country: DE
Tacalyx is a biotechnology company that develops novel anti-TACA immunotherapies to treat cancer and contentious diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2019 | Seed Round | 6 | $7.7M |
Boehringer Ingelheim Venture Fund coparion Creathor Ventures High-Tech Grunderfonds Idinvest Partners Kurma Partners Boehringer Ingelheim Venture Fund coparion Creathor Ventures High-Tech Grunderfonds Idinvest Partners Kurma Partners |
9/2019 | Seed | $7.7M |
Boehringer Ingelheim Venture Fund Kurma Partners Idinvest Partners High-Tech Gründerfonds coparion Creathor Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|